Skip to main content

Table 4 Factors associated with local progression in HCCs showing a complete response according to mRECIST and complete lipiodol retention

From: Lipiodol retention pattern after TACE for HCC is a predictor for local progression in lesions with complete response

 With local progression
N = 10
Without Local progression N = 20p value*
Serum AFP level (μg /L) ± SD31 ± 36124 ± 3400.40
HCC size (mm) ± SD22 ± 923 ± 120.78
HCC location 
 - Right lobe9 (90%)14 (70%)0.22
 - Left Lobe1 (10%)6 (30%) 
Capsule Appearance3 (30%)7 (35%)0.14
CBCT guidance3 (30%)10 (50%)0.44
Selective cTACE Treatment8 (80%)15 (75%)0.76
Mean Delivered Dose (mg) ± SD19 ± 1229 ± 14<0.01
Presence of gas on follow-up CT1 (10%)0 (0%)0.33
Embolization Agent   
- Gelitaspon10 (100%)16 (80%)0.48
- PVA particles0 (0%)3 (15%)
- No embolization0 (0%)1 (5%)
  1. *Chi2 test and t-test were used for analysis of discrete and continuous variables respectively
  2. AFP Alpha-fetoprotein, CBCT Cone beam computed tomography, HCC Hepatocellular carcionoma, PVA Polyvinyl alcohol, SD Standard deviation, cTACE Conventional transarterial chemoembolization